Breast Cancer News and Research

Latest Breast Cancer News and Research

EntreMed presents preclinical data for ENMD-2076 in triple-negative breast cancer

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, announced today the presentation of preclinical data from a study to assess the role of p53 family tumor suppressors in mediating response to ENMD-2076 in triple-negative breast cancer (TNBC).

21 Oct 2013

Bioengineers build novel tool to visualize protein networks from breast cancer cell data

A colorful wheel developed by Rice University bioengineers to visualize protein interactions has won an international competition for novel strategies to study the roots of breast cancer.

21 Oct 2013

New investigational drug offers potential treatment option for lung cancer

PF-06463922, an investigational drug being developed by Pfizer Inc., has the potential to become a new treatment option for patients who have lung cancer harboring abnormalities in the ALK gene, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

21 Oct 2013

New small-molecule inhibitor shows promising results in drug-resistant melanoma, breast cancer

LEE011, a small-molecule inhibitor of cyclin-dependent kinases (CDK) 4/6 being developed by Novartis Oncology, showed promising results in drug-resistant melanoma and drug-resistant breast cancer when tested in combination with other targeted therapies, and based on these preclinical results, several phase I clinical trials were launched recently, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held October 19-23.

21 Oct 2013

New research identifies internal timepiece that accurately gauge age of human organs and tissues

Everyone grows older, but scientists don't really understand why. Now a UCLA study has uncovered a biological clock embedded in our genomes that may shed light on why our bodies age and how we can slow the process.

21 Oct 2013

Research: Hypermutation in cancer is more frequent in inactive X chromosome

Every case of cancer originates from changes in a person's genetic material (mutations). These usually occur as "somatic mutations" in individual cells during an individual's lifetime, rather than being inherited from a person's parents.

19 Oct 2013

Eye Am Empowered: A social media support network for women experiencing life challenges

Facebook, move over. There's a new social media network in town, and it's called Eye Am Empowered. This life-changing social media support network is an innovative way for women to share, inspire, and empower each other. EyeAmEmpowered.com is the brainchild of Chrislie Formulations, a beauty company created by women, for women.

18 Oct 2013

Women diagnosed with breast cancer are 39% more likely to develop second cancer

Women diagnosed with invasive breast cancer are 39% more likely to develop a second cancer in a different part of the body. Such is the conclusion of a recent study, pioneered by female Spanish researchers.

18 Oct 2013

Good news: Knowing risk early, women can take action to prevent osteoporosis

On World Osteoporosis Day, October 20, the International Osteoporosis Foundation (IOF) is calling for women to take action now to protect their bone health. Broken bones due to osteoporosis often result in pain, immobility and loss of quality of life as well as early death.

17 Oct 2013

Scientists identify 127 mutated genes that appear to drive development of tumors in the body

Examining 12 major types of cancer, scientists at Washington University School of Medicine in St. Louis have identified 127 repeatedly mutated genes that appear to drive the development and progression of a range of tumors in the body. The discovery sets the stage for devising new diagnostic tools and more personalized cancer treatments.

17 Oct 2013

Researchers discover why women with BRCA gene develop breast and ovarian cancer

Researchers announced today in the journal Lancet Oncology that they are well on the way to discovering why women with the faulty genes BRCA 1 and BRCA 2, one of which was inherited by the actress Angelina Jolie, develop breast and ovarian cancer rather than other cancers.

17 Oct 2013

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation , today announced the results of the MPACT phase III clinical trial of ABRAXANE® in combination with gemcitabine were published online in the October 16th edition of the New England Journal of Medicine.

17 Oct 2013

Detroit Lions, Josephine Ford Cancer Institute to raise $15M for cancer research in metro Detroit

The Detroit Lions and Josephine Ford Cancer Institute, Michigan's largest provider of adult cancer care, have created a unique partnership with the goal to raise $15 million during the next three years for cancer research in metro Detroit.

16 Oct 2013

Breast cancer patients receiving nerve block with general anesthesia have less cancer recurrence

Breast cancer patients who received the combination of a nerve block with general anesthesia for their breast cancer surgery had less cancer recurrence and were three times less likely to die than those who received only general anesthesia, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.

16 Oct 2013

University of Sydney's free public talk to focus on halting superbug apocalypse

Everyday activities such as kissing, touching and sharing food can lead to the spread of a new kind of superbug that is as dangerous as it is resistant.

15 Oct 2013

Study evaluates economic cost of cancer across 27 countries of the EU

The first ever study to evaluate the economic cost of cancer across the 27 countries of the EU has found that the total cost of cancer in the EU in 2009 was €126 billion, with cancer in Germany, France, Italy, and the UK together accounting for just over two-thirds of this cost (€83 billion).

15 Oct 2013

Results announced for Phase II PRECEDENT trial of vintafolide for treatment of platinum-resistant ovarian cancer

Merck, known as MSD outside the United States and Canada, (NYSE: MRK) and Endocyte, Inc. (NASDAQ: ECYT) today announced the online publication of results from the randomized Phase II PRECEDENT trial for vintafolide (MK-8109/EC145), an investigational folate small molecule drug conjugate (SMDC), in the Journal of Clinical Oncology (JCO), the official journal of the American Society of Clinical Oncology.

15 Oct 2013

New optical imaging technique can accurately differentiate breast cancer subtypes

An optical imaging technique that measures metabolic activity in cancer cells can accurately differentiate breast cancer subtypes, and it can detect responses to treatment as early as two days after therapy administration, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.

15 Oct 2013

Researchers create online database of disease genes that could be targeted with drugs

Researchers at Washington University School of Medicine in St. Louis have created a massive online database that matches thousands of genes linked to cancer and other diseases with drugs that target those genes.

14 Oct 2013

Non-hormonal chronic pain treatment reduces moderate-to-severe hot flashes

Menopausal women suffer from half as many hot flashes after receiving a non-hormonal chronic pain treatment, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.

14 Oct 2013

Breast Cancer News and Research

Latest Breast Cancer News and Research

EntreMed presents preclinical data for ENMD-2076 in triple-negative breast cancer

Bioengineers build novel tool to visualize protein networks from breast cancer cell data

New investigational drug offers potential treatment option for lung cancer

New small-molecule inhibitor shows promising results in drug-resistant melanoma, breast cancer

New research identifies internal timepiece that accurately gauge age of human organs and tissues

Research: Hypermutation in cancer is more frequent in inactive X chromosome

Eye Am Empowered: A social media support network for women experiencing life challenges

Women diagnosed with breast cancer are 39% more likely to develop second cancer

Good news: Knowing risk early, women can take action to prevent osteoporosis

Scientists identify 127 mutated genes that appear to drive development of tumors in the body

Researchers discover why women with BRCA gene develop breast and ovarian cancer

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Detroit Lions, Josephine Ford Cancer Institute to raise $15M for cancer research in metro Detroit

Breast cancer patients receiving nerve block with general anesthesia have less cancer recurrence

University of Sydney's free public talk to focus on halting superbug apocalypse

Study evaluates economic cost of cancer across 27 countries of the EU

Results announced for Phase II PRECEDENT trial of vintafolide for treatment of platinum-resistant ovarian cancer

New optical imaging technique can accurately differentiate breast cancer subtypes

Researchers create online database of disease genes that could be targeted with drugs

Non-hormonal chronic pain treatment reduces moderate-to-severe hot flashes

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Breast Cancer News and Research

Latest Breast Cancer News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in